A
Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body; 4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
& Total Voting Rights Futura Medical plc (AIM: FUM) ( Futura or the Company ), a pharmaceutical company developing a portfolio of innovative products based on its proprietary, transdermal DermaSys® drug delivery technology and currently focused on sexual health and pain, announces that it has received a conversion notice from HT Riverwood Multi-Growth Fund ( Riverwood ), a fund managed by Atlantis Investment Management Limited ( Atlantis ), in respect of £1.5 million in principal amount of the convertible loan notes issued by the Company on 4 March 2021. This notice represents the final conversion and following this there will be no further amounts outstanding to Riverwood. Pursuant to the conversion, the Company will issue, in aggregate, 7,500,000 new ordinary shares of 0.2 pence each in the capital of the Company (the Conversion Shares ) at a conversion price of 20 pence per Ordinary Share.